Victor Biton

6.3k total citations
78 papers, 4.1k citations indexed

About

Victor Biton is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Victor Biton has authored 78 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Psychiatry and Mental health, 60 papers in Pediatrics, Perinatology and Child Health and 29 papers in Cellular and Molecular Neuroscience. Recurrent topics in Victor Biton's work include Epilepsy research and treatment (68 papers), Pharmacological Effects and Toxicity Studies (58 papers) and Neuroscience and Neuropharmacology Research (28 papers). Victor Biton is often cited by papers focused on Epilepsy research and treatment (68 papers), Pharmacological Effects and Toxicity Studies (58 papers) and Neuroscience and Neuropharmacology Research (28 papers). Victor Biton collaborates with scholars based in United States, United Kingdom and Germany. Victor Biton's co-authors include Bassel Abou‐Khalil, G. David Rudd, Pamela Doty, Georgia Montouris, Michael R. Sperling, Anne E. Hammer, Ilo E. Leppik, Gregory L. Krauss, Elinor Ben‐Menachem and James J. Cereghino and has published in prestigious journals such as JAMA, Neurology and Epilepsia.

In The Last Decade

Victor Biton

78 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Victor Biton 3.3k 2.9k 1.5k 471 402 78 4.1k
William E. Rosenfeld 2.3k 0.7× 1.9k 0.7× 1.2k 0.8× 254 0.5× 102 0.3× 87 2.8k
Ahmad Beydoun 1.8k 0.6× 1.4k 0.5× 758 0.5× 176 0.4× 946 2.4× 121 3.6k
Antonio Laurenza 2.3k 0.7× 1.7k 0.6× 1.5k 1.0× 170 0.4× 413 1.0× 93 3.3k
Pavel Klein 2.0k 0.6× 1.5k 0.5× 1.3k 0.9× 99 0.2× 286 0.7× 98 2.7k
D. Schmidt 1.7k 0.5× 1.3k 0.5× 788 0.5× 236 0.5× 87 0.2× 75 2.4k
Tapani Keränen 1.3k 0.4× 820 0.3× 705 0.5× 142 0.3× 189 0.5× 93 2.6k
Stanley R. Resor 1.4k 0.4× 1.0k 0.3× 498 0.3× 150 0.3× 99 0.2× 45 2.5k
Rajesh Sachdeo 976 0.3× 818 0.3× 471 0.3× 178 0.4× 393 1.0× 24 1.6k
Linda J. Stephen 1.9k 0.6× 1.6k 0.6× 689 0.5× 219 0.5× 70 0.2× 44 2.1k
G. David Rudd 1.9k 0.6× 1.4k 0.5× 483 0.3× 266 0.6× 67 0.2× 34 2.4k

Countries citing papers authored by Victor Biton

Since Specialization
Citations

This map shows the geographic impact of Victor Biton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Biton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Biton more than expected).

Fields of papers citing papers by Victor Biton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Biton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Biton. The network helps show where Victor Biton may publish in the future.

Co-authorship network of co-authors of Victor Biton

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Biton. A scholar is included among the top collaborators of Victor Biton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Biton. Victor Biton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sander, Josemir W., William E. Rosenfeld, Jonathan J. Halford, et al.. (2021). Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. Epilepsia. 63(1). 139–149. 30 indexed citations
3.
Rosenfeld, William E., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications. Epilepsia. 62(12). 3016–3028. 42 indexed citations
4.
Sperling, Michael R., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study. Epilepsia. 62(12). 3005–3015. 40 indexed citations
5.
Rosenfeld, William E., Bassel Abou‐Khalil, Sami Aboumatar, et al.. (2021). Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures (1755). Neurology. 96(15_supplement). 2 indexed citations
6.
7.
Biton, Victor, Bassel F. Shneker, Dean K. Naritoku, et al.. (2013). Long-Term Tolerability and Safety of Lamotrigine Extended-Release: Pooled Analysis of Three Clinical Trials. Clinical Drug Investigation. 33(5). 359–364. 14 indexed citations
8.
Biton, Victor, António Gil‐Nagel, Martin J. Brodie, Sarah E. DeRossett, & Virinder Nohria. (2013). Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures. Epilepsy Research. 107(1-2). 138–145. 15 indexed citations
9.
Krauss, Gregory L., Michal Bar, Victor Biton, et al.. (2011). Tolerability and safety of perampanel: two randomized dose-escalation studies. Acta Neurologica Scandinavica. 125(1). 8–15. 82 indexed citations
10.
Biton, Victor, Gregory L. Krauss, Francesco Bibbiani, et al.. (2010). A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures. Epilepsia. 52(2). 234–242. 47 indexed citations
11.
Chung, Steve, Michael R. Sperling, Victor Biton, et al.. (2010). Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial. Epilepsia. 51(6). 958–967. 274 indexed citations
12.
Biton, Victor. (2008). Lacosamide for the treatment of diabetic neuropathic pain. Expert Review of Neurotherapeutics. 8(11). 1649–1660. 11 indexed citations
13.
Biton, Victor. (2006). Weight Change and Antiepileptic Drugs. The Neurologist. 12(3). 163–167. 11 indexed citations
14.
Biton, Victor. (2006). Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opinion on Drug Metabolism & Toxicology. 2(6). 1009–1018. 61 indexed citations
15.
Biton, Victor. (2004). Zonisamide: newer antiepileptic agent with multiple mechanisms of action. Expert Review of Neurotherapeutics. 4(6). 935–943. 16 indexed citations
16.
Sale, Mark, Victor Biton, Alain Vuong, et al.. (2004). A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Epilepsy & Behavior. 6(1). 63–70. 6 indexed citations
17.
Leppik, Ilo E., Victor Biton, Josemir W. Sander, & Heinz Gregor Wieser. (2003). Levetiracetam and Partial Seizure Subtypes: Pooled Data from Three Randomized, Placebo‐controlled Trials. Epilepsia. 44(12). 1585–1587. 19 indexed citations
18.
Apfel, Stuart C., Bruce T. Adornato, Roy Freeman, et al.. (2000). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy. JAMA. 284(17). 2215–2215. 274 indexed citations
19.
Montouris, Georgia, et al.. (2000). Nonfocal Generalized Tonic–Clonic Seizures: Response During Long‐Term Topiramate Treatment. Epilepsia. 41(s1). 77–81. 42 indexed citations
20.
Biton, Victor. (1997). Preliminary Open‐Label Experience with Topiramate in Primary Generalized Seizures. Epilepsia. 38(s1). S42–4. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Rosenfeld Breakdown of academic impact, for papers by Ahmad Beydoun Breakdown of academic impact, for papers by Antonio Laurenza Breakdown of academic impact, for papers by Pavel Klein Breakdown of academic impact, for papers by D. Schmidt Breakdown of academic impact, for papers by Tapani Keränen Breakdown of academic impact, for papers by Stanley R. Resor Breakdown of academic impact, for papers by Rajesh Sachdeo Breakdown of academic impact, for papers by Linda J. Stephen Breakdown of academic impact, for papers by G. David Rudd
Rankless by CCL
2026